mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
AT13387 |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
CIL70 |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.7 |
mRNA |
cediranib |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.7 |
mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
SKI-II |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
BMS-754807 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
BRD-K79669418 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.7 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |